Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
University of Göttingen · Scripps Clinic · +12 more institutions
Abstract
Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.
To assess the efficacy and safety of 24 or 48 weeks of treatment with peginterferon-alpha2a plus a low or standard dose of ribavirin.
Citation impact
- FWCI
- 116.92
- Percentile
- 100%
- References
- 20
Authors
15- SJStephanos J. HadziyannisCorresponding
University of Göttingen, Scripps Clinic, Universitätsmedizin Göttingen, Icahn School of Medicine at Mount Sinai, Instituto de Infectologia Emílio Ribas, Hospital General Universitario De Valencia, Henry Dunant Hospital, Azienda Ospedaliero Universitaria San Giovanni Battista, La Roche College, North Shore University Hospital, Mayo Clinic in Arizona, Saarland University, Long Beach Medical Center, Hôpital Beaujon
- HSHoel Sette
Universitätsmedizin Göttingen
- TRTimothy R. Morgan
Universitätsmedizin Göttingen
- VBVijayan Balan
Universitätsmedizin Göttingen
- MDMoises Diago
Universitätsmedizin Göttingen
Topics & keywords
- Ribavirin
- Medicine
- Internal medicine
- Gastroenterology
- Hepatitis C
- Alpha interferon
- Hepatitis C virus
- Interferon
- Good health and well-being